Reports for ATORVASTATIN
Ingredient
ATORVASTATIN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CADUET | 10MG 10MG | TABLET | Resolved | 2023-02-14 | 2023-03-20 | 184556 |
| CADUET | 20MG 10MG | TABLET | Resolved | 2023-03-20 | 2023-06-13 | 187500 |
| MYLAN-ATORVASTATIN | 20MG | TABLET | Resolved | 2017-10-13 | 2018-10-16 | 25898 |
| MYLAN-ATORVASTATIN | 80MG | TABLET | Resolved | 2017-08-15 | 2018-10-24 | 19456 |
| MYLAN-ATORVASTATIN | 80MG | TABLET | Resolved | 2019-03-20 | 2019-04-04 | 79012 |
| MYLAN-ATORVASTATIN | 80MG | TABLET | Resolved | 2020-04-02 | 2020-05-26 | 110438 |
| MINT-ATORVASTATIN | 10MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217690 |
| MINT-ATORVASTATIN | 20MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217693 |
| MINT-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217696 |
| MYLAN-AMLODIPINE/ATORVASTATIN | 5MG 10MG | TABLET | Resolved | 2017-07-24 | 2017-08-04 | 16832 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
| APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
| APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |